NYLIM VP Wellington Small Cap Portfolio

S000053035NEW YORK LIFE INVESTMENTS VP FUNDS TRUSTCIK 0000887340

Share classes

No share classes in the SEC snapshot.

2,774 filed series have no class in company_tickers_mf.json, so no ticker can be reached for them.

Share classes

Report period

1 period filed. Holdings below describe the selected month only.

2026-03-31

Filing

NPORT-P · filed 2026-05-26

Report date: 2026-03-31
Net assets: $356,350,248.31
Total assets: $368,239,177.73
Total liabilities: $11,888,929.42
Assets invested: $0
Cash not reported in C or D: $549,483.26
Amendment: No
Accession: 0002071691-26-011380

By asset category

N-PORT Item C.4.a

ECEquity - common$338.73M92.3%

STIVShort-term investment veh…$16.42M4.5%

OTHEROther; the filer describe…$11.68M3.2%

DEDerivative - equity$30.0K0.0%

By asset category

By issuer category

N-PORT Item C.4.b

CORPCorporate$338.73M92.3%

RFRegistered fund$28.10M7.7%

OTHEROther; the filer describe…$30.0K0.0%

By issuer category

By investment country

as filed

USUS$337.44M92.0%

ILIL$6.52M1.8%

BMBM$6.10M1.7%

KYKY$5.27M1.4%

By country

Classification look-through

Positions resolved to the master through ISIN, then rolled up through the taxonomy. 88.0% of reported value reaches a classification.

Equity · Information Technology(34)$59.14M16.1%

Equity · Financials(31)$55.63M15.2%

Equity · Health Care(96)$50.70M13.8%

Equity · Consumer Discretionary(23)$42.53M11.6%

Equity · Industrials(18)$35.33M9.6%

Not resolved to the master(15)$29.56M8.1%

Equity · Energy(13)$24.64M6.7%

Equity · Real Estate(9)$15.49M4.2%

Equity · Utilities(7)$14.36M3.9%

Resolved, not yet classified(5)$14.35M3.9%

Equity · Materials(7)$13.05M3.6%

Equity · Consumer Staples(4)$5.89M1.6%

Equity(2)$3.29M0.9%

Equity · Communication Services(2)$2.92M0.8%

Classification covers part of the master. 5,771 of 13,106 active securities are classified. Anything unclassified is shown as its own band rather than dropped, so a look-through total that falls short of 100% is telling you about coverage, not about the fund.

Percentages are of the reported value of positions above ($366.87M), not of the fund’s net assets ($356.35M). The two differ by cash, derivatives filed with no market value, and rounding.

Classification look-through

Holdings

266 positions in this filing

Issuer nameAsset categoryIssuer category

Holdings

Issuer↕	In master	CUSIP / ISIN	Asset	Balance↕	Value↕	Weight▼	Country
TG Therapeutics, Inc.	TGTX	88322Q108 US88322Q1085	EC CORP	9,873 NS	$328.0K	0.092%	US
Dave, Inc.	DAVE	23834J201 US23834J2015	EC CORP	1,817 NS	$316.3K	0.089%	US
Rhythm Pharmaceuticals, Inc.	RYTM	76243J105 US76243J1051	EC CORP	3,616 NS	$314.5K	0.088%	US
Soleno Therapeutics, Inc.	—	834203309 US8342033094	EC CORP	9,308 NS	$311.6K	0.087%	US
Terns Pharmaceuticals, Inc.	—	880881107 US8808811074	EC CORP	5,688 NS	$299.9K	0.084%	US
Viridian Therapeutics, Inc.	VRDN	92790C104 US92790C1045	EC CORP	15,148 NS	$296.3K	0.083%	US
CRISPR Therapeutics AG	CRSP	— CH0334081137	EC CORP	5,741 NS	$273.1K	0.077%	CH
Dianthus Therapeutics, Inc.	DNTH	252828108 US2528281080	EC CORP	3,170 NS	$266.0K	0.075%	US
Ligand Pharmaceuticals, Inc.	LGND	53220K504 US53220K5048	EC CORP	1,302 NS	$259.9K	0.073%	US
Mirum Pharmaceuticals, Inc.	MIRM	604749101 US6047491013	EC CORP	2,689 NS	$248.4K	0.070%	US
Alight, Inc. Alight, Inc., Class A	—	01626W101 US01626W1018	EC CORP	425,555 NS	$248.0K	0.070%	US
Inspire Medical Systems, Inc.	INSP	457730109 US4577301090	EC CORP	4,778 NS	$246.4K	0.069%	US
Indivior Pharmaceuticals, Inc.	INDV	45579U109 US45579U1097	EC CORP	8,077 NS	$246.2K	0.069%	US
MBX Biosciences, Inc.	MBX	55287L101 US55287L1017	EC CORP	8,077 NS	$241.1K	0.068%	US
IonQ, Inc.	IONQ	46222L108 US46222L1089	EC CORP	7,844 NS	$226.1K	0.063%	US
Hims & Hers Health, Inc.	HIMS	433000106 US4330001060	EC CORP	10,861 NS	$225.5K	0.063%	US
Prestige Consumer Healthcare, Inc.	PBH	74112D101 US74112D1019	EC CORP	3,368 NS	$199.6K	0.056%	US
Catalyst Pharmaceuticals, Inc.	—	14888U101 US14888U1016	EC CORP	7,650 NS	$189.4K	0.053%	US
Tarsus Pharmaceuticals, Inc.	TARS	87650L103 US87650L1035	EC CORP	2,648 NS	$185.8K	0.052%	US
Supernus Pharmaceuticals, Inc.	SUPN	868459108 US8684591089	EC CORP	3,577 NS	$184.9K	0.052%	US
Twist Bioscience Corp.	TWST	90184D100 US90184D1000	EC CORP	3,883 NS	$184.5K	0.052%	US
Erasca, Inc.	ERAS	29479A108 US29479A1088	EC CORP	11,347 NS	$183.6K	0.052%	US
ACADIA Pharmaceuticals, Inc.	ACAD	004225108 US0042251084	EC CORP	8,229 NS	$183.2K	0.051%	US
Genius Sports Ltd.	GENI	— GG00BMF1JR16	EC CORP	40,990 NS	$181.6K	0.051%	GG
Ideaya Biosciences, Inc.	IDYA	45166A102 US45166A1025	EC CORP	5,409 NS	$180.2K	0.051%	US
Arcutis Biotherapeutics, Inc.	ARQT	03969K108 US03969K1088	EC CORP	7,262 NS	$171.1K	0.048%	US
ImmunityBio, Inc.	IBRX	45256X103 US45256X1037	EC CORP	22,038 NS	$169.0K	0.047%	US
Denali Therapeutics, Inc.	DNLI	24823R105 US24823R1059	EC CORP	8,786 NS	$168.7K	0.047%	US
Travere Therapeutics, Inc.	TVTX	89422G107 US89422G1076	EC CORP	5,673 NS	$168.5K	0.047%	US
Veracyte, Inc.	VCYT	92337F107 US92337F1075	EC CORP	5,189 NS	$167.1K	0.047%	US
Janus Living, Inc. Janus Living, Inc., Class A-1	JAN	471024109 US4710241096	EC CORP	7,000 NS	$165.0K	0.046%	US
Liquidia Corp.	LQDA	53635D202 US53635D2027	EC CORP	4,160 NS	$157.0K	0.044%	US
BioCryst Pharmaceuticals, Inc.	BCRX	09058V103 US09058V1035	EC CORP	16,132 NS	$153.6K	0.043%	US
Beam Therapeutics, Inc.	BEAM	07373V105 US07373V1052	EC CORP	6,392 NS	$152.3K	0.043%	US
Vera Therapeutics, Inc.	VERA	92337R101 US92337R1014	EC CORP	3,773 NS	$151.8K	0.043%	US
Dyne Therapeutics, Inc.	DYN	26818M108 US26818M1080	EC CORP	8,048 NS	$145.9K	0.041%	US
Edgewise Therapeutics, Inc.	EWTX	28036F105 US28036F1057	EC CORP	4,513 NS	$142.2K	0.040%	US
iShares Russell 2000 Growth ETF	IWO	464287648 US4642876480	OTHER RF	453 NS	$142.2K	0.040%	US
ADMA Biologics, Inc.	ADMA	000899104 US0008991046	EC CORP	15,676 NS	$141.2K	0.040%	US
Syndax Pharmaceuticals, Inc.	SNDX	87164F105 US87164F1057	EC CORP	5,755 NS	$134.4K	0.038%	US
Immunome, Inc.	IMNM	45257U108 US45257U1088	EC CORP	6,040 NS	$132.1K	0.037%	US
Agios Pharmaceuticals, Inc.	AGIO	00847X104 US00847X1046	EC CORP	3,801 NS	$128.6K	0.036%	US
Amneal Pharmaceuticals, Inc.	AMRX	03168L105 US03168L1052	EC CORP	10,284 NS	$127.8K	0.036%	US
Oruka Therapeutics, Inc.	ORKA	687604108 US6876041087	EC CORP	2,486 NS	$121.9K	0.034%	US
GRAIL, Inc.	GRAL	384747101 US3847471014	EC CORP	2,350 NS	$121.4K	0.034%	US
Definium Therapeutics, Inc.	DFTX	24477V105 CA24477V1058	EC CORP	6,314 NS	$119.3K	0.033%	CA
Immunovant, Inc.	IMVT	45258J102 US45258J1025	EC CORP	4,696 NS	$116.6K	0.033%	US
Arcus Biosciences, Inc.	RCUS	03969F109 US03969F1093	EC CORP	5,363 NS	$115.8K	0.033%	US
Aurinia Pharmaceuticals, Inc.	AUPH	05156V102 CA05156V1022	EC CORP	7,650 NS	$113.4K	0.032%	CA
Vericel Corp.	VCEL	92346J108 US92346J1088	EC CORP	3,417 NS	$109.9K	0.031%	US

Issuer↕

In master

CUSIP / ISIN

Asset

Balance↕

Value↕

Weight▼

Country

TG Therapeutics, Inc.

TGTX

88322Q108

US88322Q1085

CORP

9,873 NS

$328.0K

0.092%

Dave, Inc.

DAVE

23834J201

US23834J2015

CORP

1,817 NS

$316.3K

0.089%

Rhythm Pharmaceuticals, Inc.

RYTM

76243J105

US76243J1051

CORP

3,616 NS

$314.5K

0.088%

Soleno Therapeutics, Inc.

—

834203309

US8342033094

CORP

9,308 NS

$311.6K

0.087%

Terns Pharmaceuticals, Inc.

—

880881107

US8808811074

CORP

5,688 NS

$299.9K

0.084%

Viridian Therapeutics, Inc.

VRDN

92790C104

US92790C1045

CORP

15,148 NS

$296.3K

0.083%

CRISPR Therapeutics AG

CRSP

—

CH0334081137

CORP

5,741 NS

$273.1K

0.077%

Dianthus Therapeutics, Inc.

DNTH

252828108

US2528281080

CORP

3,170 NS

$266.0K

0.075%

Ligand Pharmaceuticals, Inc.

LGND

53220K504

US53220K5048

CORP

1,302 NS

$259.9K

0.073%

Mirum Pharmaceuticals, Inc.

MIRM

604749101

US6047491013

CORP

2,689 NS

$248.4K

0.070%

Alight, Inc.

Alight, Inc., Class A

—

01626W101

US01626W1018

CORP

425,555 NS

$248.0K

0.070%

Inspire Medical Systems, Inc.

INSP

457730109

US4577301090

CORP

4,778 NS

$246.4K

0.069%

Indivior Pharmaceuticals, Inc.

INDV

45579U109

US45579U1097

CORP

8,077 NS

$246.2K

0.069%

MBX Biosciences, Inc.

MBX

55287L101

US55287L1017

CORP

8,077 NS

$241.1K

0.068%

IonQ, Inc.

IONQ

46222L108

US46222L1089

CORP

7,844 NS

$226.1K

0.063%

Hims & Hers Health, Inc.

HIMS

433000106

US4330001060

CORP

10,861 NS

$225.5K

0.063%

Prestige Consumer Healthcare, Inc.

PBH

74112D101

US74112D1019

CORP

3,368 NS

$199.6K

0.056%

Catalyst Pharmaceuticals, Inc.

—

14888U101

US14888U1016

CORP

7,650 NS

$189.4K

0.053%

Tarsus Pharmaceuticals, Inc.

TARS

87650L103

US87650L1035

CORP

2,648 NS

$185.8K

0.052%

Supernus Pharmaceuticals, Inc.

SUPN

868459108

US8684591089

CORP

3,577 NS

$184.9K

0.052%

Twist Bioscience Corp.

TWST

90184D100

US90184D1000

CORP

3,883 NS

$184.5K

0.052%

Erasca, Inc.

ERAS

29479A108

US29479A1088

CORP

11,347 NS

$183.6K

0.052%

ACADIA Pharmaceuticals, Inc.

ACAD

004225108

US0042251084

CORP

8,229 NS

$183.2K

0.051%

Genius Sports Ltd.

GENI

—

GG00BMF1JR16

CORP

40,990 NS

$181.6K

0.051%

Ideaya Biosciences, Inc.

IDYA

45166A102

US45166A1025

CORP

5,409 NS

$180.2K

0.051%

Arcutis Biotherapeutics, Inc.

ARQT

03969K108

US03969K1088

CORP

7,262 NS

$171.1K

0.048%

ImmunityBio, Inc.

IBRX

45256X103

US45256X1037

CORP

22,038 NS

$169.0K

0.047%

Denali Therapeutics, Inc.

DNLI

24823R105

US24823R1059

CORP

8,786 NS

$168.7K

0.047%

Travere Therapeutics, Inc.

TVTX

89422G107

US89422G1076

CORP

5,673 NS

$168.5K

0.047%

Veracyte, Inc.

VCYT

92337F107

US92337F1075

CORP

5,189 NS

$167.1K

0.047%

Janus Living, Inc.

Janus Living, Inc., Class A-1

JAN

471024109

US4710241096

CORP

7,000 NS

$165.0K

0.046%

Liquidia Corp.

LQDA

53635D202

US53635D2027

CORP

4,160 NS

$157.0K

0.044%

BioCryst Pharmaceuticals, Inc.

BCRX

09058V103

US09058V1035

CORP

16,132 NS

$153.6K

0.043%

Beam Therapeutics, Inc.

BEAM

07373V105

US07373V1052

CORP

6,392 NS

$152.3K

0.043%

Vera Therapeutics, Inc.

VERA

92337R101

US92337R1014

CORP

3,773 NS

$151.8K

0.043%

Dyne Therapeutics, Inc.

DYN

26818M108

US26818M1080

CORP

8,048 NS

$145.9K

0.041%

Edgewise Therapeutics, Inc.

EWTX

28036F105

US28036F1057

CORP

4,513 NS

$142.2K

0.040%

iShares Russell 2000 Growth ETF

IWO

464287648

US4642876480

OTHER

453 NS

$142.2K

0.040%

ADMA Biologics, Inc.

ADMA

000899104

US0008991046

CORP

15,676 NS

$141.2K

0.040%

Syndax Pharmaceuticals, Inc.

SNDX

87164F105

US87164F1057

CORP

5,755 NS

$134.4K

0.038%

Immunome, Inc.

IMNM

45257U108

US45257U1088

CORP

6,040 NS

$132.1K

0.037%

Agios Pharmaceuticals, Inc.

AGIO

00847X104

US00847X1046

CORP

3,801 NS

$128.6K

0.036%

Amneal Pharmaceuticals, Inc.

AMRX

03168L105

US03168L1052

CORP

10,284 NS

$127.8K

0.036%

Oruka Therapeutics, Inc.

ORKA

687604108

US6876041087

CORP

2,486 NS

$121.9K

0.034%

GRAIL, Inc.

GRAL

384747101

US3847471014

CORP

2,350 NS

$121.4K

0.034%

Definium Therapeutics, Inc.

DFTX

24477V105

CA24477V1058

CORP

6,314 NS

$119.3K

0.033%

Immunovant, Inc.

IMVT

45258J102

US45258J1025

CORP

4,696 NS

$116.6K

0.033%

Arcus Biosciences, Inc.

RCUS

03969F109

US03969F1093

CORP

5,363 NS

$115.8K

0.033%

Aurinia Pharmaceuticals, Inc.

AUPH

05156V102

CA05156V1022

CORP

7,650 NS

$113.4K

0.032%

Vericel Corp.

VCEL

92346J108

US92346J1088

CORP

3,417 NS

$109.9K

0.031%